DermTech, Inc. (DMTK): Price and Financial Metrics


DermTech, Inc. (DMTK): $6.42

0.40 (+6.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DMTK POWR Grades


  • Growth is the dimension where DMTK ranks best; there it ranks ahead of 28.04% of US stocks.
  • The strongest trend for DMTK is in Sentiment, which has been heading down over the past 179 days.
  • DMTK's current lowest rank is in the Quality metric (where it is better than 1.4% of US stocks).

DMTK Stock Summary

  • DMTK's price/sales ratio is 38.23; that's higher than the P/S ratio of 95.36% of US stocks.
  • DMTK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 6.33% of US stocks.
  • With a year-over-year growth in debt of 2,245.67%, DermTech Inc's debt growth rate surpasses 99.27% of about US stocks.
  • Stocks that are quantitatively similar to DMTK, based on their financial statements, market capitalization, and price volatility, are LMND, PRCH, SSTI, FUBO, and CVLT.
  • Visit DMTK's SEC page to see the company's official filings. To visit the company's web site, go to www.dermtech.com.

DMTK Valuation Summary

  • DMTK's price/earnings ratio is -21.6; this is 159.18% lower than that of the median Healthcare stock.
  • DMTK's price/earnings ratio has moved NA NA over the prior 51 months.
  • DMTK's price/earnings ratio has moved NA NA over the prior 51 months.

Below are key valuation metrics over time for DMTK.

Stock Date P/S P/B P/E EV/EBIT
DMTK 2021-08-31 120.7 4.1 -21.6 -17.1
DMTK 2021-08-30 118.5 4.0 -21.2 -16.7
DMTK 2021-08-27 119.4 4.1 -21.4 -16.9
DMTK 2021-08-26 114.1 3.9 -20.4 -15.9
DMTK 2021-08-25 114.6 3.9 -20.5 -16.0
DMTK 2021-08-24 116.1 4.0 -20.8 -16.3

DMTK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DMTK has a Quality Grade of F, ranking ahead of 1.78% of graded US stocks.
  • DMTK's asset turnover comes in at 0.055 -- ranking 76th of 81 Healthcare stocks.
  • LFMD, AHCO, and RHE are the stocks whose asset turnover ratios are most correlated with DMTK.

The table below shows DMTK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.055 0.128 -1.299
2021-03-31 0.060 0.010 -1.492
2020-12-31 0.089 -0.016 -1.875
2020-09-30 0.101 -0.020 -3.873
2020-06-30 0.102 -0.017 12.100
2020-03-31 0.117 0.141 -20.696

DMTK Price Target

For more insight on analysts targets of DMTK, see our DMTK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $62.00 Average Broker Recommendation 1.25 (Strong Buy)

DMTK Stock Price Chart Interactive Chart >

Price chart for DMTK

DMTK Price/Volume Stats

Current price $6.42 52-week high $48.32
Prev. close $6.02 52-week low $5.68
Day low $5.96 Volume 589,100
Day high $6.45 Avg. volume 756,803
50-day MA $10.70 Dividend yield N/A
200-day MA $19.98 Market Cap 192.22M

DermTech, Inc. (DMTK) Company Bio


DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.


DMTK Latest News Stream


Event/Time News Detail
Loading, please wait...

DMTK Latest Social Stream


Loading social stream, please wait...

View Full DMTK Social Stream

Latest DMTK News From Around the Web

Below are the latest news stories about DermTech Inc that investors may wish to consider to help them evaluate DMTK as an investment opportunity.

DermTech Management to Present at Upcoming Investor Conferences

LA JOLLA, Calif., February 24, 2022--DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that its management will present at the following upcoming conferences:

Yahoo | February 24, 2022

DermTech Welcomes Adelle Walker as Vice President of Consumer Products

LA JOLLA, Calif., February 23, 2022--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the addition of Adelle Walker to the organization as Vice President of Consumer Products. Walker takes on this new role as DermTech further invests in bringing its precision genomics platform to the skin health and wellness categories.

Yahoo | February 23, 2022

DermTech to Announce Fourth Quarter and Full-Year Financial Results

LA JOLLA, Calif., February 15, 2022--DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that it plans to release its fourth quarter and full-year 2021 financial results after the market closes on Tuesday, March 1, 2022. In conjunction with such release, the Company plans to host a conference call and webcast that day at 1:30 p.m. Pacific time / 4:30 p.m. Eastern time to discuss its financial results and

Yahoo | February 15, 2022

Is DermTech, Inc.'s (NASDAQ:DMTK) Shareholder Ownership Skewed Towards Insiders?

If you want to know who really controls DermTech, Inc. ( NASDAQ:DMTK ), then you'll have to look at the makeup of its...

Yahoo | February 14, 2022

Ausdal Financial Partners, Inc. Buys Ford Motor Co, Uber Technologies Inc, SPDR Portfolio ...

Investment company Ausdal Financial Partners, Inc. (Current Portfolio) buys Ford Motor Co, Uber Technologies Inc, SPDR Portfolio S&P 600 Small Cap ETF, Twitter Inc, Micron Technology Inc, sells VanEck Investment Grade Floating Rate ETF, Block Inc, ETFMG Alternative Harvest ETF, The Energy Select Sector SPDR Fund, AbbVie Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Ausdal Financial Partners, Inc..

Yahoo | February 8, 2022

Read More 'DMTK' Stories Here

DMTK Price Returns

1-mo -35.54%
3-mo -48.39%
6-mo -67.41%
1-year -83.02%
3-year N/A
5-year N/A
YTD -59.37%
2021 -51.29%
2020 161.61%
2019 -39.28%
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.8421 seconds.